the aid library

Filter

338

Download

View PDF

GBD PROFILE: MOZAMBIQUE

Institute for Health Metrics and Evaluation (2010)

Download

View PDF

Zoonotic diseases of public health importance

National Institue of communicable Diseases, India (1998) C1

Download

View PDF

Lineamientos técnicos para el abordaje integral, multidisciplinario e interinstitucional a las personas con pie diabético

José, F.; C G. Alvarenga Cardoza, K.M. Díaz de Naves Ministerio de Salud El Salvador (2021) C1

Technical guidelines for a comprehensive, multidisciplinary and inter-institutional approach to people with diabetic neuropathy

Download

View PDF

Inter-Agency Reproductive Health Kits 6th Edition - Manual

Inter-Agency Working Group on Reproductive Health in Crisis IAWG and UNFPA (2021) C1

Download

View PDF

Saving Mothers, Giving Life. Maternal Mortality Endline Census in Selected Districts

Central Statistical Office (CSO) Zambia, Ministry of Health (MOH) Zambia, and ICF, et al. (2017) C1

Download

View PDF

WHO recommendations on the management of diarrhoea and pneumonia in HIV-infected infants and children

World Health Organization (2010) C_WHO

To improve survival and quality of life among the 2.5 million children living with HIV, a comprehensive package of prevention, care and treatment is required. This package should include management of infections such as pneumonia, diarrhoea, malaria and ear infections, as well as common opportunisti ... more

Download

View PDF

Care of Small and Sick Newborns in Special Newborn Care Units (SNCUs) of India: Two year report April 2013 – March 2015

Ministry of Health & Family Welfare, Government of India (2017) C2

This report provides a comprehensive overview of the progress made by India in terms of establishment and functionality of Special Newborn Care Units (SNCUs) during the two year period from April 2013 to March 2015. It describes the progress in the operational status (numbers, bed strength, human re ... more

Download

View PDF

Falldefinitionen des Robert Koch-Instituts zur Übermittlung von Erkrankungs- oder Todesfällen und Nachweisen von Krankheitserregern (2016)

Robert Koch-Institut (2016) C1

gemäß § 4 Abs. 2 des Gesetzes zur Verhütung und Bekämpfung von Infektionskrankhei ten beim Menschen (Infektionsschutzgesetz - I fSG)

Download

View PDF

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for ... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download

View PDF

The Pediatric Clinical Manual

Elaine Abrams, Wafaa El-Sadr, and Miriam Rabkin The International Center for AIDS Programm (2004)

Download

View PDF

Paediatrics for Doctors in Papua New Guinea

Frank Shann and John Vince (2003)

A guide for doctors providing health services for children. 2nd edition

External Link

Essential Package of Health Services (EPHS). Secondary & Tertiary Care: The District, County & National Health Systems (Liberia)
recommended

Ministry of Health & Social Welfare, Liberia (2011) C1

Essential Drug list on page 36!!

Download

View PDF

WHO recommendations for prevention and treatment of maternal peripartum infections

World Health Organization WHO (2015) C_WHO

Download

View PDF

UNFPA Myanmar Annual Report 2017

United Nations Population Fund (UNFPA) (2018) C1

Ensuring reproductive rights for all

Download

View PDF

Treat as One. Bridging the gap between mental and physical healthcare in general hospitals

National Confidential Enquiry into Patient Outcome and Death (2017) C1

This NCEPOD report highlights the quality of mental health and physical health care for patients aged 18 years or older with a significant mental disorder who are admitted to a general hospital. The report takes a critical look at areas where the care of patients might have been improved. Remediable ... more

Download

View PDF

Directiva sanitaria para la vigilancia epidemiológica de la enfermedad por coronavirus (COVID-19) en el Perú

Ministerio de Salud, Peru (2021) CC

La presente establece los lineamientos y procedimientos para la vigilancia epidemiológica de COVID-19 en el país. Asimismo, los procedimientos, metodología e instrumentos para la vigilancia epidemiológica de COVID-19 en pacientes hospitalizados y las defunciones por COVID-19 en el país.

Download

View PDF

Evaluation of COVID-19 vaccine effectiveness in a changing landscape of COVID-19 epidemiology and vaccination

World Health Organization WHO (2022) C_WHO

Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method ... more

Download

View PDF

Emergency Illnesses and Major Injuries Affecting Infants and Children; Including Adolescent Girls Who Are Pregnant

Maternal & Childhealth Advocacy International MCAI (2021) C1

Handbook 1

Download

View PDF

Corticosteroids for COVID-19

World Health Organization WHO (2020) C_WHO

WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19. We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ... more

External Link

Rapid Health Assessment Protocols for Emergencies

World Health Organization WHO (1999) C_WHO

Essential Package of Health Services (EPHS). Secondary & Tertiary Care: The District, County & National Health Systems (Liberia) recommended

Essential Package of Health Services (EPHS). Secondary & Tertiary Care: The District, County & National Health Systems (Liberia)
recommended